Product Information
COZAAR 100 MG TABLET is a brand product labeled by Organon LLC, priced at $6.1400 per EA under NDC 78206012301. Its NADAC has been published 264 times since Sep 15, 2021.
FDA first approved this application on Apr 14, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the losartan potassium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Organon LLCNDC
78206012301
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOSARTAN POTASSIUMApproval Type
New Drug (NDA)
FDA Application
NDA020386FDA Approved
4/14/1995
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for COZAAR 100 MG TABLET has been published 264 times since Sep 15, 2021, and over the history we have for it it has risen 27.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.1400 per EA |
|---|---|
| All-time high | $6.1559 (Aug 12, 2026) |
| All-time low | $4.8222 (Sep 15, 2021) |
| 52-week high | $6.1559 |
| 52-week low | $5.8458 |
| Median price | $5.5876 |
| Average price | $5.5621 |
| Largest weekly change | +6.0% (Jan 18, 2023) |
| Weeks tracked | 264 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
losartan potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COZAAR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COZAAR 100 MG TABLET, manufactured by Organon LLC, is $6.1400 per EA (NDC 78206012301), effective Sep 30, 2026.
How has the price of COZAAR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for COZAAR 100 MG TABLET has risen 27.3%. It has been tracked across 264 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for COZAAR 100 MG TABLET?
Since Sep 15, 2021, the NADAC for COZAAR 100 MG TABLET has ranged from a low of $4.8222 (Sep 15, 2021) to a high of $6.1559 (Aug 12, 2026), with a median of $5.5876 per EA.
Are there cheaper alternatives to COZAAR 100 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN POTASSIUM 100 MG TAB, is $0.0445 per EA — about 99% below COZAAR 100 MG TABLET.
Who manufactures COZAAR 100 MG TABLET?
COZAAR 100 MG TABLET (NDC 78206012301) is labeled by Organon LLC, and CMS classifies it as a brand product.